Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/1996
05/15/1996EP0711831A2 Rabbit G protein coupled receptor
05/15/1996EP0711829A2 Recombinant alphavirus vectors
05/15/1996EP0711563A1 Novel Borrelia vaccine
05/15/1996EP0711415A1 Immunoassay for detecting collagen or collagen fragments
05/15/1996EP0711355A1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
05/15/1996EP0711349A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
05/15/1996EP0711345A1 B7-2: ctl a4/cd 28 counter receptor
05/15/1996EP0711344A1 Modified alpha-lactalbumin
05/15/1996EP0711310A1 Human antibodies against varicella-zoster virus
05/15/1996EP0711305A1 Protegrins
05/15/1996EP0711304A1 Nickel-free hemoglobin and methods for producing such hemoglobin
05/15/1996EP0711174A1 Programmed cell death genes and proteins
05/15/1996EP0711173A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof
05/15/1996EP0537168B1 Ctaa 28a32, the antigen recognized by mca 28a32
05/15/1996EP0482013B1 Nonglycosylated human interleukin-3 analog proteins
05/15/1996EP0438474B1 Production of antibodies from transgenic animals
05/15/1996DE19509279C1 Dermatomyositis-spezifisches Autoantigen Dermatomyositis-specific autoantigen
05/15/1996CA2162799A1 G protein coupled receptor protein, production and use thereof
05/14/1996US5516938 Sulfonylurea linking component
05/14/1996US5516895 Antibodies specific towards gp 48
05/14/1996US5516691 Module for culturing and using metabolisms and/or for maintaining microorganisms
05/14/1996US5516682 Subtilin variant of enhanced stability and activity
05/14/1996US5516679 Genetic engineering
05/14/1996US5516677 Desulfurization of fuel or oil
05/14/1996US5516658 DNA encoding cytokines that bind the cell surface receptor hek
05/14/1996US5516655 Multiple drug resistance gene of Aureobasidium pullulans
05/14/1996US5516653 Genetic engineering
05/14/1996US5516652 DNA encoding prostaglandin receptor IP
05/14/1996US5516639 Antibodies specific for human prostate glandular kallkrein
05/14/1996US5516637 Genetic engineering; expression
05/14/1996CA2060951C Starches with an improved flavour
05/14/1996CA1338324C Monoclonal antibody for the selective immunological determination of intact procollagen peptide (type iii) and procollagen (type iii) in body fluids
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013601A1 Controlled enzyme biodegradation of organic natural fibers and method for releasing contaminants
05/09/1996WO1996013599A1 Nucleic acid transfer system
05/09/1996WO1996013592A2 Protein kinase npk-110
05/09/1996WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996WO1996013585A1 A novel family of protease inhibitors, and other biologic active substances
05/09/1996WO1996013583A2 Targeted hetero-association of recombinant proteins to multi-functional complexes
05/09/1996WO1996013523A1 Cathepsin o2 protease
05/09/1996WO1996013518A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
05/09/1996WO1996013516A1 Peptide sequence that forms mucin sugar chain and technique for modifying protein to be linked with mucin sugar chain
05/09/1996WO1996013515A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof
05/09/1996WO1996013274A1 Process for production of inhibited forms of activated blood factors
05/09/1996WO1996007734A3 Recombinant adenovirus comprising a chimeric penton base protein
05/09/1996CA2204037A1 Novel opacity associated proteins, dna encoding the same, and methods of use thereof
05/09/1996CA2203925A1 Biological product for the physico-chemical stabilisation of wines
05/09/1996CA2203910A1 Novel protein kinase (npk-110)
05/09/1996CA2203827A1 Novel family of protease inhibitors, and other biologic active substances
05/09/1996CA2203807A1 Process for production of inhibited forms of activated blood factors
05/08/1996EP0710723A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica
05/08/1996EP0710722A1 Genetic mechanisms of tumor suppression
05/08/1996EP0710719A1 Generation of xenogeneic antibodies
05/08/1996EP0710362A1 Methods for determining the invasiveness of a bladder tumor
05/08/1996EP0710295A1 Htlv-ii nra? compositions and assays for detecting htlv infection
05/08/1996EP0710288A1 Adenoviral vectors for treatment of hemophilia
05/08/1996EP0710286A1 Methods and dna expression systems for over-expression of proteins in host cells
05/08/1996EP0710285A1 Analogues of an anti-thrombin polypeptide and process for their preparation
05/08/1996EP0710283A1 EXPRESSION OF HUMAN INTERLEUKIN-1$g(b) IN A TRANSGENIC ANIMAL
05/08/1996EP0710253A1 Antibodies specific for human prostate glandular kallikrein
05/08/1996EP0710252A1 Monoclonal antibodies to egg yolk immunoglobulins (igy)
05/08/1996EP0710248A1 Melanoma-inhibiting protein
05/08/1996EP0710244A1 Immunoreactive reagents employing monoamine oxidase
05/08/1996EP0710110A1 Rapamycin conjugates and antibodies
05/08/1996EP0642524A4 Systemin.
05/08/1996EP0423198B1 Antibodies specific towards hiv 1 gp 48
05/08/1996EP0328578B1 Antigen recognized by mca 16-88
05/08/1996CN1122139A Improved HCV diagnostic agents
05/08/1996CN1121927A High-efficiency low-toxic human tumor necrosis factor
05/08/1996CN1031759C Process for preparing monoclonal antibody specific to common determinant site of neutrophils and eosinophils
05/07/1996US5514786 Compositions for inhibiting RNA activity
05/07/1996US5514648 Fungicidally active compounds
05/07/1996US5514600 Mammalian guanine nucleotide binding protein with an ADP-ribosylation factor domain
05/07/1996US5514599 Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays
05/07/1996US5514586 Plasmid vectors and GRAS microorganisms promoting ice nucleation
05/07/1996US5514585 Yeast processing system
05/07/1996US5514578 Genetic engineering
05/07/1996US5514544 Dna sequences for genetic engineering
05/07/1996CA1338310C Polycyclic peptide antibiotic and method for production thereof
05/07/1996CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
05/02/1996WO1996012964A1 Receptor for a bacillus thuringiensis toxin
05/02/1996WO1996012816A1 Process for producing proteins
05/02/1996WO1996012810A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
05/02/1996WO1996012809A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996WO1996012808A1 Nucleic acid preparation for immunization and method for immunization using the same
05/02/1996WO1996012807A2 Hepatitis e virus antigens and uses therefor
05/02/1996WO1996012805A1 Alk-7 (activin like kinase), a serine threonine kinase receptor
05/02/1996WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996WO1996012801A1 Oral immunization with transgenic plants
05/02/1996WO1996012799A1 Neutralization of foof allergens by thioredoxin
05/02/1996WO1996012791A1 Human abh
05/02/1996WO1996012735A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding
05/02/1996WO1996012733A1 Major outer membrane protein cd of moraxella
05/02/1996WO1996012732A1 Novel peptide and therapeutic agent
05/02/1996WO1996012501A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2
05/02/1996WO1996012397A2 Recombinant antibody capable of binding to pna/nucleic acid complexes
05/02/1996WO1996009386A3 Allelic variation of the serotonin 5ht2c receptor
05/02/1996CA2652992A1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
05/02/1996CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof
1 ... 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 ... 1125